Nabumeton Tillomed (Nabumetone)

• Nabumetone is an NSAID that reduces inflammation and pain in several musculoskeletal conditions.
• Rheumatoid arthritis: alleviates joint inflammation and pain, helping preserve function.
• Osteoarthritis: decreases cartilage‑related discomfort and improves mobility.
• Ankylosing spondylitis: reduces spinal inflammation and stiffness.
• Acute pain: provides rapid relief of short‑term nociceptive pain.
• Musculoskeletal disorders: eases pain and swelling associated with injuries or overuse.

• Nabumetone is a pro‑drug that is metabolised to its active form, which selectively inhibits cyclooxygenase (COX) enzymes, particularly COX‑2. By blocking COX‑mediated conversion of arachidonic acid to prostaglandins, it lowers the production of inflammatory mediators, thereby reducing pain, swelling, and fever associated with inflammatory conditions.

Nabumetone may cause a range of adverse reactions, from mild to severe. Awareness of these effects helps clinicians monitor patients appropriately.

Common Side Effects

• Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain.
• Headache: mild to moderate intensity.
• Dizziness or vertigo.
• Elevated liver enzymes: transient increase in hepatic transaminases.
• Skin rash: mild erythema or pruritus.

Serious or Rare Side Effects

• Peptic ulcer disease or gastrointestinal bleeding.
• Severe hepatic injury: jaundice or hepatitis.
• Renal impairment: acute kidney injury or reduced renal function.
• Cardiovascular events: increased risk of myocardial infarction or stroke.
• Severe hypersensitivity reactions: anaphylaxis or Stevens‑Johnson syndrome.
• Blood dyscrasias: agranulocytosis or thrombocytopenia.

• Before prescribing Nabumetone, clinicians should evaluate patient risk factors and monitor for adverse outcomes.
• Assess renal function: check baseline creatinine and monitor periodically.
• Evaluate hepatic status: perform liver function tests before and during therapy.
• Screen for gastrointestinal risk: consider ulcer prophylaxis in high‑risk patients.
• Avoid in patients with known hypersensitivity to NSAIDs: discontinue immediately if reaction occurs.
• Use caution in cardiovascular disease: assess benefit‑risk balance.
• Store at ambient temperature: keep in the original container, protect from moisture and heat.

Nabumetone can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased bleeding risk.
• Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity.
• High‑dose aspirin: additive renal and gastric effects.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: possible reduction in renal function.
• Diuretics: enhanced risk of renal impairment.
• Lithium: NSAIDs may raise lithium serum levels.
• Methotrexate: reduced clearance leading to toxicity.
• Corticosteroids: synergistic increase in ulcer risk.